Prevention of postoperative deep-vein thrombosis by low-dose heparin in open prostatectomy. 1980

M Vandendris, and M Kutnowski, and B Futeral, and X Gianakopoulos, and M Kraytman, and W Gregoir

A double-blind trial was designed to investigate the efficacy of low-dose heparin in preventing deep-vein thrombosis (DVT) after open prostatectomy... The diagnosis of DVT was established by the 125I-fibrinogen test. The incidence of DVT was 39.4% in the control group (33 patients) and 9.7% in the heparin group (31 patients) (p less than 0.01). These results suggest that low-dose heparin effectively prevents DVT after open prostatectomy

UI MeSH Term Description Entries
D008297 Male Males
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011468 Prostatectomy Complete or partial surgical removal of the prostate. Three primary approaches are commonly employed: suprapubic - removal through an incision above the pubis and through the urinary bladder; retropubic - as for suprapubic but without entering the urinary bladder; and transurethral (TRANSURETHRAL RESECTION OF PROSTATE). Prostatectomy, Retropubic,Prostatectomy, Suprapubic,Prostatectomies,Prostatectomies, Retropubic,Prostatectomies, Suprapubic,Retropubic Prostatectomies,Retropubic Prostatectomy,Suprapubic Prostatectomies,Suprapubic Prostatectomy
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013924 Thrombophlebitis Inflammation of a vein associated with a blood clot (THROMBUS). Phlegmasia Alba Dolens,Dolens, Phlegmasia Alba,Thrombophlebitides

Related Publications

M Vandendris, and M Kutnowski, and B Futeral, and X Gianakopoulos, and M Kraytman, and W Gregoir
July 1985, Journal of the Royal Society of Medicine,
M Vandendris, and M Kutnowski, and B Futeral, and X Gianakopoulos, and M Kraytman, and W Gregoir
January 1982, Phlebologie,
M Vandendris, and M Kutnowski, and B Futeral, and X Gianakopoulos, and M Kraytman, and W Gregoir
April 1980, Lancet (London, England),
M Vandendris, and M Kutnowski, and B Futeral, and X Gianakopoulos, and M Kraytman, and W Gregoir
November 1972, Drug and therapeutics bulletin,
M Vandendris, and M Kutnowski, and B Futeral, and X Gianakopoulos, and M Kraytman, and W Gregoir
April 1981, Scottish medical journal,
M Vandendris, and M Kutnowski, and B Futeral, and X Gianakopoulos, and M Kraytman, and W Gregoir
January 1976, Semaine des hopitaux. Therapeutique,
M Vandendris, and M Kutnowski, and B Futeral, and X Gianakopoulos, and M Kraytman, and W Gregoir
February 1982, British medical journal (Clinical research ed.),
M Vandendris, and M Kutnowski, and B Futeral, and X Gianakopoulos, and M Kraytman, and W Gregoir
November 1971, The British journal of surgery,
M Vandendris, and M Kutnowski, and B Futeral, and X Gianakopoulos, and M Kraytman, and W Gregoir
May 1978, Lancet (London, England),
M Vandendris, and M Kutnowski, and B Futeral, and X Gianakopoulos, and M Kraytman, and W Gregoir
December 1973, Lancet (London, England),
Copied contents to your clipboard!